Prevest Denpro [PREVEST] vs Tarsons Products [TARSONS] Detailed Stock Comparison
Prevest Denpro
BSE
Loading...
Tarsons Products
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Prevest Denpro wins in 11 metrics, Tarsons Products wins in 7 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Prevest Denpro | Tarsons Products | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.86 | 66.74 | Prevest Denpro |
| Price-to-Book Ratio | 6.35 | 3.15 | Tarsons Products |
| Debt-to-Equity Ratio | 0.00 | 53.82 | Prevest Denpro |
| PEG Ratio | N/A | 30.14 | N/A |
| EV/EBITDA | 26.13 | 19.95 | Tarsons Products |
| Profit Margin (TTM) | 28.81% | 7.59% | Prevest Denpro |
| Operating Margin (TTM) | 32.92% | 15.08% | Prevest Denpro |
| EBITDA Margin (TTM) | 32.92% | 15.08% | Prevest Denpro |
| Return on Equity | 18.70% | 4.79% | Prevest Denpro |
| Return on Assets (TTM) | 12.17% | 2.94% | Prevest Denpro |
| Free Cash Flow (TTM) | $128.49M | $-374.69M | Prevest Denpro |
| Dividend Yield | N/A | 0.53% | N/A |
| 1-Year Return | 3.30% | -11.67% | Prevest Denpro |
| Price-to-Sales Ratio (TTM) | 10.63 | 5.07 | Tarsons Products |
| Enterprise Value | $5.77B | $22.09B | Tarsons Products |
| EV/Revenue Ratio | 9.16 | 5.63 | Tarsons Products |
| Gross Profit Margin (TTM) | 86.70% | 66.37% | Prevest Denpro |
| Revenue per Share (TTM) | $53 | $74 | Tarsons Products |
| Earnings per Share (Diluted) | $15.14 | $5.60 | Prevest Denpro |
| Beta (Stock Volatility) | 0.51 | 0.11 | Tarsons Products |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Prevest Denpro vs Tarsons Products Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Prevest Denpro | -0.54% | 1.45% | 3.87% | 15.53% | 14.34% | -7.00% |
| Tarsons Products | -3.75% | -0.35% | -2.02% | -0.03% | 5.28% | -7.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Prevest Denpro | 3.30% | 65.82% | 110.57% | 110.57% | 110.57% | 110.57% |
| Tarsons Products | -11.67% | -50.13% | -54.33% | -54.33% | -54.33% | -54.33% |
Performance & Financial Health Analysis: Prevest Denpro vs Tarsons Products
| Metric | PREVEST | TARSONS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.70B | ₹19.89B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,120 | 23,739 |
| 90 Day Avg. Volume | 12,460 | 32,034 |
| Last Close | ₹555.00 | ₹359.75 |
| 52 Week Range | ₹393.60 - ₹686.00 | ₹280.00 - ₹494.95 |
| % from 52W High | -19.10% | -27.32% |
| All-Time High | ₹686.00 (Jan 13, 2025) | ₹924.90 (Nov 29, 2021) |
| % from All-Time High | -19.10% | -61.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.07% |
| Quarterly Earnings Growth | 0.08% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.08% |
| Operating Margin (TTM) | 0.33% | 0.15% |
| Return on Equity (TTM) | 0.19% | 0.05% |
| Debt to Equity (MRQ) | 0.00 | 53.82 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹87.89 | ₹118.59 |
| Cash per Share (MRQ) | ₹54.61 | ₹4.83 |
| Operating Cash Flow (TTM) | ₹148.17M | ₹1.14B |
| Levered Free Cash Flow (TTM) | ₹106.82M | ₹-769,583,744 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.53% |
| Last 12-Month Dividend | N/A | ₹2.00 |
Valuation & Enterprise Metrics Analysis: Prevest Denpro vs Tarsons Products
| Metric | PREVEST | TARSONS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.86 | 66.74 |
| Forward P/E | N/A | 30.14 |
| PEG Ratio | N/A | 30.14 |
| Price to Sales (TTM) | 10.63 | 5.07 |
| Price to Book (MRQ) | 6.35 | 3.15 |
| Market Capitalization | ||
| Market Capitalization | ₹6.70B | ₹19.89B |
| Enterprise Value | ₹5.77B | ₹22.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.16 | 5.63 |
| Enterprise to EBITDA | 26.13 | 19.95 |
| Risk & Other Metrics | ||
| Beta | 0.51 | 0.11 |
| Book Value per Share (MRQ) | ₹87.89 | ₹118.59 |
Financial Statements Comparison: Prevest Denpro vs Tarsons Products
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PREVEST | TARSONS |
|---|---|---|
| Revenue/Sales | ₹184.55M | ₹1.13B |
| Cost of Goods Sold | ₹24.54M | ₹378.93M |
| Gross Profit | ₹160.01M | ₹747.98M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹60.76M | ₹169.95M |
| EBITDA | ₹76.23M | ₹408.04M |
| Pre-Tax Income | ₹71.51M | ₹155.71M |
| Income Tax | ₹20.16M | ₹53.68M |
| Net Income (Profit) | ₹51.41M | ₹102.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PREVEST | TARSONS |
|---|---|---|
| Cash & Equivalents | ₹608.98M | ₹251.31M |
| Total Current Assets | ₹857.16M | ₹2.43B |
| Total Current Liabilities | ₹59.62M | ₹1.76B |
| Long-Term Debt | ₹0 | ₹2.12B |
| Total Shareholders Equity | ₹1.06B | ₹6.30B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹268.13M | ₹4.72B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PREVEST | TARSONS |
|---|---|---|
| Operating Cash Flow | N/A | ₹100.02M |
| Capital Expenditures | N/A | ₹-279.63M |
| Free Cash Flow | N/A | ₹-231.27M |
| Debt Repayment | N/A | ₹-754.90M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PREVEST | TARSONS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,120 | 23,739 |
| Average Daily Volume (90 Day) | 12,460 | 32,034 |
| Shares Outstanding | 12.00M | 53.21M |
| Float Shares | 2.61M | 13.38M |
| % Held by Insiders | 0.78% | 0.75% |
| % Held by Institutions | 0.00% | 0.08% |
Dividend Analysis & Yield Comparison: Prevest Denpro vs Tarsons Products
| Metric | PREVEST | TARSONS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹2.00 |
| Last 12-Month Dividend Yield | N/A | 0.53% |
| 3-Year Avg Annual Dividend | N/A | ₹0.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹2.00 |
| Ex-Dividend Date | N/A | Sep 20, 2024 |